These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2721257)

  • 21. An evaluation of the efficacy and safety of azelastine in patients with chronic asthma. Azelastine-Asthma Study Group.
    J Allergy Clin Immunol; 1996 Jun; 97(6):1218-24. PubMed ID: 8648016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azelastine: a multifaceted drug for asthma therapy.
    Szelenyi I; Achterrath-Tuckermann U; Schmidt J; Minker E; Paegelow I; Werner H
    Agents Actions Suppl; 1991; 34():295-311. PubMed ID: 1686526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary N-methylhistamine in asthmatic children receiving azelastine hydrochloride.
    Takei S; Shimago A; Iwashita M; Kumamoto T; Kamuro K; Miyata K
    Ann Allergy Asthma Immunol; 1997 May; 78(5):492-6. PubMed ID: 9164363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of an oral gold compound, auranofin, on bronchial responsiveness to inhaled methacholine in well-controlled bronchial asthma].
    Honma M; Tamura G; Taniguchi Y; Takishima T
    Arerugi; 1991 Dec; 40(12):1470-6. PubMed ID: 1793366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic evaluation of azelastine in subjects with asthma.
    Spector SL; Perhach JL; Rohr AS; Rachelefsky GS; Katz RM; Siegel SC
    J Allergy Clin Immunol; 1987 Jul; 80(1):75-80. PubMed ID: 3298379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma.
    Amayasu H; Yoshida S; Ebana S; Yamamoto Y; Nishikawa T; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Ishizaki Y
    Ann Allergy Asthma Immunol; 2000 Jun; 84(6):594-8. PubMed ID: 10875487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic protective effects with azelastine and salbutamol in a guinea pig asthma model.
    Chand N; Achterrath-Tuckermann U; Szelenyi I; Sofia RD
    Res Commun Mol Pathol Pharmacol; 1995 Feb; 87(2):125-32. PubMed ID: 7749650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The study of bronchial hyperresponsiveness in asthmatic children by forced oscillation technique.
    Wang JY
    Asian Pac J Allergy Immunol; 1991 Jun; 9(1):51-6. PubMed ID: 1776980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
    Achterrath-Tuckermann U; Weischer CH; Szelenyi I
    Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma.
    Takemura M; Niimi A; Matsumoto H; Ueda T; Matsuoka H; Yamaguchi M; Jinnai M; Chin K; Mishima M
    Respiration; 2012; 83(4):308-15. PubMed ID: 22094623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cough threshold for capsaicin increases by azelastine in patients with cough-variant asthma.
    Shioya T; Ito N; Sasaki M; Kagaya M; Sano M; Shindo T; Kashima M; Miura M
    Pulm Pharmacol; 1996 Feb; 9(1):59-62. PubMed ID: 8843511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis.
    Gyllfors P; Kumlin M; Dahlén SE; Gaber F; Ehrs PO; Dahlén B
    Thorax; 2005 Nov; 60(11):902-8. PubMed ID: 16055619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of azelastine on endotoxin-induced airway hyperresponsiveness in mice.
    Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Okamoto K; Adachi M
    Int Arch Allergy Immunol; 1995 Nov; 108(3):292-7. PubMed ID: 7580296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis.
    van Grunsven PM; van Schayck CP; Molema J; Akkermans RP; van Weel C
    Thorax; 1999 Apr; 54(4):316-22. PubMed ID: 10092692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is normal bronchial responsiveness in asthmatics a reliable index for withdrawing inhaled corticosteroid treatment?
    Marabini A; Cardinalini G; Severini C; Ripandelli A; Siracusa A
    Chest; 1998 Apr; 113(4):964-7. PubMed ID: 9554632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of azelastine on bronchial mucosa in bronchial asthma--suppression of cytokine mRNA].
    Shimojo J
    Arerugi; 1998 Jun; 47(6):604-13. PubMed ID: 9721452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate.
    Gyllfors P; Dahlén SE; Kumlin M; Larsson K; Dahlén B
    J Allergy Clin Immunol; 2006 Jul; 118(1):78-83. PubMed ID: 16815141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls.
    Adelroth E; Morris MM; Hargreave FE; O'Byrne PM
    N Engl J Med; 1986 Aug; 315(8):480-4. PubMed ID: 3526153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bronchial hyperresponsiveness and relaxability in patients with mitral stenosis].
    Ohnishi H; Maeda H; Nishimura Y; Takenaka K; Yahata T; Takatsuki K; Nakamura H; Yokoyama M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Nov; 32(11):1061-6. PubMed ID: 7815758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.